Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 5/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 4/20 | 0.41 |
| ▸ | LDLR | P01130 | 13/20 | 0.37 |
| ▸ | PCSK9 | Q8NBP7 | 13/20 | 0.37 |
| ▸ | ROR1 | Q01973 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGAV | P06756 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.36 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20963294 | 0.82 | SSTR2 (0.52) | SSTR2SSTR5LDLRPCSK9SSTR3 | |
| SCHEMBL21892339 | 0.78 | SSTR2 (0.56) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL24348111 | 0.70 | SSTR2 (0.45) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL20465752 | 0.66 | SSTR2 (0.69) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL24347585 | 0.66 | SSTR2 (0.36) | SSTR2SSTR5LDLRPCSK9SSTR3 | |
| SCHEMBL21892055 | 0.65 | SSTR2 (0.70) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL20465794 | 0.65 | SSTR2 (0.70) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL18712329 | 0.65 | SSTR2 (0.61) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL22183489 | 0.65 | SSTR2 (0.69) | SSTR2SSTR5SSTR3SSTR4SSTR1 | |
| SCHEMBL18712893 | 0.63 | SSTR2 (0.70) | SSTR2SSTR5SSTR3SSTR4SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220096646-A1 | SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF | TVA (ABC), LLC | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096646-A1 | SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF | SSTR1, SSTR4, SSTR3 | SSTR2 5/4885SSTR5 4/4885LDLR 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.